Stay updated on AK102 Q6W Clinical Trial in Hyperlipidemia
Sign up to get notified when there's something new on the AK102 Q6W Clinical Trial in Hyperlipidemia page.

Latest updates to the AK102 Q6W Clinical Trial in Hyperlipidemia page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has been updated to reflect a new completion status and a specific date of March 6, 2025, while previous statuses and dates have been removed.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check46 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check75 days agoChange DetectedThe website has updated the intervention type to 'Verified 2022-02 by Akeso' and noted that the last known status is 'Recruiting', while the previous revision (v2.13.3) has been removed.SummaryDifference2%
Stay in the know with updates to AK102 Q6W Clinical Trial in Hyperlipidemia
Enter your email address, and we'll notify you when there's something new on the AK102 Q6W Clinical Trial in Hyperlipidemia page.